Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Ga-68-IAC Positron Emission Tomography (PET/CT) for Diagnosis and Clinical Management in Metastatic Breast Cancer Patients.

NCT04480619 is registered in ClinicalTrials.gov with Advanced Imaging Projects, LLC as lead sponsor.

NCT NCT04480619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04480619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Ga-68-IAC Positron Emission Tomography (PET/CT) for Diagnosis and Clinical Management in Metastatic Breast Cancer Patients.
Lead sponsor
Advanced Imaging Projects, LLC
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
October 30, 2025
Completion date
August 30, 2027
Enrollment
25 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

angiogenic breast cancer